本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

OncoMed Pharmaceuticals, Inc.

0.8900
+0.0000
成交量:- -
成交額:- -
市值:3,443.42萬
市盈率:-4.22
高:0.8900
開:0.8900
低:0.8900
收:0.8900
資料載入中...
2019/04/26

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/04/24

員工持股計劃

Securities to be offered to employees in employee benefit plans, post-effective amendments
2019/04/24

員工持股計劃

Securities to be offered to employees in employee benefit plans, post-effective amendments
2019/04/24

員工持股計劃

Securities to be offered to employees in employee benefit plans, post-effective amendments
2019/04/24

員工持股計劃

Securities to be offered to employees in employee benefit plans, post-effective amendments
2019/04/24

員工持股計劃

Securities to be offered to employees in employee benefit plans, post-effective amendments
2019/04/24

員工持股計劃

Securities to be offered to employees in employee benefit plans, post-effective amendments
2019/04/23

交易所摘牌聲明

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2019/04/17

企業合併公告

Prospectuses and communications, business combinations
2019/03/15

企業合併公告

Prospectuses and communications, business combinations
2019/03/15

企業合併公告

Prospectuses and communications, business combinations
2019/03/12

企業合併公告

Prospectuses and communications, business combinations
2019/02/22

企業合併公告

Prospectuses and communications, business combinations
2019/02/15

企業合併公告

Prospectuses and communications, business combinations
2019/02/12

企業合併公告

Prospectuses and communications, business combinations
2019/02/11

企業合併公告

Prospectuses and communications, business combinations
2019/01/07

企業合併公告

Prospectuses and communications, business combinations
2018/12/26

SEC問詢函

Statement of changes in beneficial ownership of securities
2018/12/11

企業合併公告

Prospectuses and communications, business combinations
2018/12/06

企業合併公告

Prospectuses and communications, business combinations